Showing results (31-40 of 225) with videos related to
Sort By:
Pageof 23
Molecules (Basel, Switzerland)|June 24, 2022
Accum™ Technology: A Novel Conjugable Primer for Onco-ImmunotherapyAbed El-Hakim El-Kadiry, Simon Beaudoin, Sebastien Plouffe, et al.Blood Advances|May 9, 2020
Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune matchJayeeta Giri, Jacques GalipeauCancer Immunology, Immunotherapy : CII|January 25, 2008
TGF beta secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effectClaudia Penafuerte, Jacques GalipeauStem Cells Translational Medicine|November 14, 2014
Concise review: engineering the fusion of cytokines for the modulation of immune cellular responses in cancer and autoimmune disordersSpencer Ng, Jacques GalipeauJournal of Immunology (Baltimore, Md. : 1950)|May 5, 2011
GM-CSF-based fusion cytokines as ligands for immune modulationPatrick Williams, Jacques GalipeauInfectious Disorders Drug Targets|March 8, 2012
Reprogramming of B cells into regulatory cells with engineered fusokinesJiusheng Deng, Jacques GalipeauOncoimmunology|June 22, 2012
FIST, a sword and shield fusokine for cancer immunotherapyClaudia Penafuerte, Jacques GalipeauJournal of Visualized Experiments : Jove|July 18, 2022
Teasing Out the Interplay Between Natural Killer Cells and Nociceptor NeuronsAli Ahmadi, Mohammad Balood, Katiane Roversi, et al.Journal of Cellular Physiology|March 2, 2012
New insights on translational development of mesenchymal stromal cells for suppressor therapyMoïra François, Jacques GalipeauPageof 23